Will the Use of Triesence During Glaucoma Surgery Provide Lower Eye Pressure and Improve the Results of the Surgery?

• Status: Completed
• Trial end date: 2012-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The investigators hypothesize that intracameral Triesence during glaucoma surgery will provide lower intraocular pressure through better control of ocular inflammation, thus leading to a more successful filtering procedure.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Wills Eye
• Collaborator: Alcon Research
• Treatments: Pharmaceutical Solutions; Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide

Criteria

Inclusion Criteria:

• glaucoma patients requiring surgery (Trabeculectomy or Express Shunt; Trabeculectomy plus Phacoemulsification and Interocular Lens Implant; Baerveldt Tube; Ahmed Tube; Molteno Tube)

• primary open angle glaucoma

• primary angle-closure glaucoma

• pseudoexfoliation glaucoma

• pigmentary glaucoma

• traumatic glaucoma

• neovascular glaucoma

Exclusion Criteria:

• patients that are pregnant, nursing, or not using adequate contraception

• any other eye surgery except cataract surgery

• an infection, inflammation, or any abnormality preventing measurement of eye pressure

• enrolled in another investigational study